web analytics
16.3 C
Munich
Saturday, May 28, 2022

ProText Mobility, Inc. (OTCMKTS: TXTM) Heating Up as Accumulation Continues (JV & RSAMMD Update)

ProText Mobility, Inc. (OTCMKTS: TXTM) is on the rise northbound and volume is picking up as the stock is currently under heavy accumulation. While the RSAMMD reverse merger speculation that fueled the run to $0.0069 highs back in August never happened, the Company has maintained its “pink current” status and filed its annual report on April 15 showing a healthy balance sheet (for otcqb) and around $1 million in debt. The stock is attractive at current levels, priced cheap at an $11 million total market valuation TXTM has runner in its blood making 2 separate triple digit moves in 2021. While 2022 has started off slowly this can change quickly on the OTCQB and TXTM is starting to show signs of life here. 

The last we heard from the Company was in October of 2021 when they announced an LOI to acquire 100% ownership of a premier vodka Brand in the prestigious category of top shelf vodka products.  The transaction includes the acquisition of three individual Companies that comprise the (i) Brand assets, (ii) wine and spirits import license and (iii) national distribution. Upon closing, Protext will own 100% of the three individual Companies in exchange for preferred stock in Protext. This premium vodka is completely odorless without burn, Nine times distilled from the finest French grain, created and produced by a 5th generation master distiller, located in the heart of the world-famous Cognac region of France. Additional details about the transaction, brand, awards, management, and history will be made in the coming days.  The closing of the transaction is anticipated to occur within the next two weeks.    

ProText Mobility, Inc. (OTCMKTS: TXTM) operates two wholly-owned subsidiaries; Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc.  The Company is engaged in the research, clinical testing and commercialization of highly bioavailable botanical products—all-natural ingredients formulated for nutraceutical and pharmaceutical applications. 

As we reported on in our previous article on TXTM back on August 3, 2021 TXTM has a Joint Venture (JV) partnership in place with RSAMMD to test and commercialize medical grade cannabis products using TXTM’s proprietary extraction technology from live cannabis and hemp plants. This extraction technology is said to improve absorption and bioavailability of the product up to 15x. They have been working together for almost a year now. Lab testing of samples has been completed and it looks like they are slowly ramping up production and finally in the position to bring a product to market. See below for details. RSAMMD’s recent tweets have been very optimistic and ambitious – calling for multiple MMJ off-takes and one of the largest cannabis operations in the world.  

The first phase of the agreement took place at a government-licensed facility in New Castle, SA under the supervision of Dr. Ahmed Jamaloodeen, National Treasurer of the Cannabis Development Council of South Africa (CDCSA) and property owner of the 5000 Hectare Hemp farm in New Castle where the live plants were sourced, freshly cut and provided for by RSAMMD under the agreement. His wife, Dr. Regina Hurley was also on site. Dr. Hurley, is an American Board Certified Anesthesiologist, Fellowship American Pediatric Cardiac Anesthesiologist and a well known medical cannabis Activist and advocate for CBD. She is one of a handful of practitioners who advocate the use of medical marijuana for medical purposes in South Africa and is a registered physician with the American Medical Marijuana Physicians Association.  

To Find out the inside Scoop on TXTM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

TXTM

On October 29 TXTM announced it has executed a Letter of Intent to acquire 100% ownership of a premier vodka Brand in the prestigious category of top shelf vodka products.  The transaction includes the acquisition of three individual Companies that comprise the (i) Brand assets, (ii) wine and spirits import license and (iii) national distribution. Upon closing, Protext will own 100% of the three individual Companies in exchange for preferred stock in Protext. This premium vodka is completely odorless without burn, Nine times distilled from the finest French grain, created and produced by a 5th generation master distiller, located in the heart of the world-famous Cognac region of France. Additional details about the transaction, brand, awards, management, and history will be made in the coming days.  The closing of the transaction is anticipated to occur within the next two weeks.    

Mr. David Lewis, CEO commented, “Post closing, the owners of the newly acquired business will all remain on board in their current capacity, roles and titles, and are expected to play an integral role in the continued expansion of the vodka brand nationally.  As it relates to the core business of Protext, the owners have a family-related business within the hemp and cannabis space and see synergies in developing Protext’s proprietary live plant extraction technology.  Discussions are ongoing relating to a road map for the build out of an extraction system in North America using Protext’ proprietary methods, processes and Kettle equipment that would be applicable to the hemp and cannabis industries.”  Prior research and trials have shown that the Kettle system, when applied to other medicinal plants, can create an extract that is significantly more bioavailable (10-15x) than a standard extract. This means that the cannabis extract should be significantly more potent requiring a smaller dose, while providing a dose that could potentially last up to 24 hours in the bloodstream, which is in-line with prior clinical results using other medicinal plants such as green tea. 

Additionally, previous research conducted at a licensed facility outside the US using the Kettle extraction equipment and running lower water temperature in the extraction process with live cannabis plant was shown to produce a cannabis emulsion that tested out having a high THC-A and a low THC level below.1%.  Those investigations demonstrated that full-spectrum cannabinoids can be extracted using the proprietary Kettle system, with minimal metabolic conversion and producing a full spectrum cannabinoid extract without the psychoactive property delivered by THC. 

Fore More on TXTM Subscribe Right Now!

Currently trading at a $11 million market valuation TXTM has a clean balance sheet with around $1 million in debt. There are currently 7,388,175,006 shares outstanding with authorized shares set at 10 billion. TXTM does have a number of things in the works; the Company has a (JV) partnership in place with RSAMMD to test and commercialize medical grade cannabis products using TXTM’s proprietary extraction technology from live cannabis and hemp plants. RSAMMD owns a 20 square mile Hemp farm, one of the biggest in the world, they also operate a significant cannabis business. While a reverse merger into TXTM by RSAMMD is still very possible, or some other qualified revenue generating business. In the meantime, TXTM most recent pr is on the LOI to acquire of a premier vodka Brand in the prestigious category of top shelf vodka productsThe transaction includes the acquisition of three individual Companies that comprise the (i) Brand assets, (ii) wine and spirits import license and (iii) national distribution. We will be updating on TXTM when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TXTM.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in TXTM either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.